NCT00263926
- Conditions
- Allergy, Hypersensitivity, Hypersensitivity, Immediate, +2 more
- Locations
-
- Allergopharma GmbH & Co. KG Reinbek, Germany
Clinical trial condition
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
NCT00263926
NCT01436617
NCT00266526
NCT00244114
Not specified
NCT00263549
NCT01191359
NCT00227279
NCT00702026
NCT00670930
NCT00461227